Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2023; Volume 64,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Haller, Bernhard

    1. <sup>177</sup>Lu-PSMA-I&amp;T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
      You have access
      177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
      Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 402-409; DOI: https://doi.org/10.2967/jnumed.122.264402
  2. Hamacher, Rainer

    1. Novel <sup>68</sup>Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
      Open Access
      Novel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
      Tristan T. Demmert, Ines Maric, Kelsey L. Pomykala, Katharina Lueckerath, Jens Siveke, Benedikt M. Schaarschmidt, Rainer Hamacher, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 368-371; DOI: https://doi.org/10.2967/jnumed.122.264872
  3. Han, Donghee

    1. Deep Learning–Based Attenuation Correction Improves Diagnostic Accuracy of Cardiac SPECT
      You have access
      Deep Learning–Based Attenuation Correction Improves Diagnostic Accuracy of Cardiac SPECT
      Aakash D. Shanbhag, Robert J.H. Miller, Konrad Pieszko, Mark Lemley, Paul Kavanagh, Attila Feher, Edward J. Miller, Albert J. Sinusas, Philipp A. Kaufmann, Donghee Han, Cathleen Huang, Joanna X. Liang, Daniel S. Berman, Damini Dey and Piotr J. Slomka
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 472-478; DOI: https://doi.org/10.2967/jnumed.122.264429
  4. Haq, Adeel

    1. You have access
      Progression or Response: New Liver Lesions in a Patient with Responding Hodgkin Lymphoma
      Ashwin Singh Parihar, Adeel Haq, Richard L. Wahl and Amin H. Jahromi
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 500; DOI: https://doi.org/10.2967/jnumed.122.264995
  5. Harbo, Frederik

    1. Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing <sup>18</sup>F-FDG PET/CT with Conventional CT
      You have access
      Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing 18F-FDG PET/CT with Conventional CT
      Marianne Vogsen, Frederik Harbo, Nick M. Jakobsen, Henriette J. Nissen, Sara E. Dahlsgaard-Wallenius, Oke Gerke, Jeanette D. Jensen, Jon T. Asmussen, Anne Marie B. Jylling, Poul-Erik Braad, Werner Vach, Marianne Ewertz and Malene G. Hildebrandt
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 355-361; DOI: https://doi.org/10.2967/jnumed.121.263358
  6. Harmon, Stephanie A.

    1. Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
      You have access
      Predicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
      Tim E. Phelps, Stephanie A. Harmon, Esther Mena, Liza Lindenberg, Joanna H. Shih, Deborah E. Citrin, Peter A. Pinto, Bradford J. Wood, William L. Dahut, James L. Gulley, Ravi A. Madan, Peter L. Choyke and Baris Turkbey
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 395-401; DOI: https://doi.org/10.2967/jnumed.122.264334
  7. Hatazawa, Jun

    1. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine
      You have access
      Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine
      Tudor M. Ionescu, Mario Amend, Tadashi Watabe, Jun Hatazawa, Andreas Maurer, Gerald Reischl, Bernd J. Pichler, Hans F. Wehrl and Kristina Herfert
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 466-471; DOI: https://doi.org/10.2967/jnumed.122.264391
  8. Heck, Matthias

    1. <sup>177</sup>Lu-PSMA-I&amp;T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
      You have access
      177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
      Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 402-409; DOI: https://doi.org/10.2967/jnumed.122.264402
  9. Herfert, Kristina

    1. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine
      You have access
      Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine
      Tudor M. Ionescu, Mario Amend, Tadashi Watabe, Jun Hatazawa, Andreas Maurer, Gerald Reischl, Bernd J. Pichler, Hans F. Wehrl and Kristina Herfert
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 466-471; DOI: https://doi.org/10.2967/jnumed.122.264391
  10. Herrmann, Ken

    1. You have access
      Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy
      Kelsey L. Pomykala, Marcus Würker and Ken Herrmann
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 347-348; DOI: https://doi.org/10.2967/jnumed.122.264900
    2. PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study
      You have access
      PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study
      Caner Civan, Stefan Kasper, Christoph Berliner, Pedro Fragoso-Costa, Viktor Grünwald, Michael Pogorzelski, Benedikt Michael Schaarschmidt, Stephan Lang, David Kersting, Michael Nader, Katharina Lückerath, Ken Herrmann, Wolfgang P. Fendler and Manuel Weber
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 372-378; DOI: https://doi.org/10.2967/jnumed.122.264342
    3. Novel <sup>68</sup>Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
      Open Access
      Novel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
      Tristan T. Demmert, Ines Maric, Kelsey L. Pomykala, Katharina Lueckerath, Jens Siveke, Benedikt M. Schaarschmidt, Rainer Hamacher, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine March 1, 2023, 64 (3) 368-371; DOI: https://doi.org/10.2967/jnumed.122.264872
« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 64 (3)
Journal of Nuclear Medicine
Vol. 64, Issue 3
March 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study
  • Development of a Lensless Radiomicroscope for Cellular-Resolution Radionuclide Imaging
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire